Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up
- 1 February 1997
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 1174-1177
- https://doi.org/10.1016/s0041-1345(96)00535-0
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- EVIDENCE THAT PEDIATRIC LIVER TRANSPLANT RECIPIENTS MAY UNDERGO LATE REJECTION EPISODES IN SPITE OF DONOR-SPECIFIC MICROCHIMERISM1Transplantation, 1996
- TIMING, SIGNIFICANCE, AND PROGNOSIS OF LATE ACUTE LIVER ALLOGRAFT REJECTIONTransplantation, 1995
- Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.1995
- Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejectionHepatology, 1994
- Donor-Type Microchimerism Associated with Graft Rejection Eight Years after Liver TransplantationNew England Journal of Medicine, 1994
- Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.1993
- Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptanceHepatology, 1993
- Cell migration, chimerism, and graft acceptanceThe Lancet, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTSTransplantation, 1992